Case of benralizumab-induced exacerbations of chronic spontaneous urticaria.

Eli MagenIrina KomarovaIsrael MagenSofia Phirtskhalava

Published in: Clinical case reports (2022)

The role of IL-5 in chronic spontaneous urticarial (CSU) is unclear. It may be that benralizumab is an important bidirectional modifier of CSU; that is, blocking IL-5 may improve CSU in some patients, but it is possible that it may worsen CSU in others.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
chronic obstructive pulmonary disease
cystic fibrosis
drug induced
prognostic factors
peritoneal dialysis
high glucose
diabetic rats
endothelial cells